Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

4D MOLECULAR THERAPEUTICS, INC.

(FDMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023
Capitalization1 1 098732--
Entreprise Value (EV)1 821414537701
P/E ratio -4,70x-8,86x-7,79x-
Yield ----
Capitalization / Revenue 80,7x40,0x472x-
EV / Revenue 60,3x22,6x346x-
EV / EBITDA -14,9x-5,77x-4,45x-3,55x
Price to Book ----
Nbr of stocks (in thousands) 26 49432 139--
Reference price (USD) 41,522,822,822,8
Announcement Date 03/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021 2022 2023
Net sales1 13,618,31,55-
EBITDA1 -55,2-71,9-121-197
Operating profit (EBIT)1 -56,7-73,4-122-198
Operating Margin -416%-401%-7 896%-
Pre-Tax Profit (EBT) ----
Net income1 -56,7-71,7-94,8-
Net margin -416%-392%-6 115%-
EPS2 -8,82-2,57-2,93-
Dividend per Share2 ----
Announcement Date 03/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 2,0014,61,370,70--
EBITDA ------
Operating profit (EBIT)1 -16,3-7,60-22,7-26,8-32,5-35,5
Operating Margin -816%-52,1%-1 659%-3 828%--
Pre-Tax Profit (EBT) ------
Net income1 -16,4-7,59-22,2-25,4--
Net margin -820%-52,1%-1 628%-3 631%--
EPS2 -0,61-0,28-0,82-0,79--
Dividend per Share ------
Announcement Date 05/13/202108/12/202111/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023
Net Debt1 ----
Net Cash position1 27731819531,3
Leverage (Debt / EBITDA) 5,01x4,42x1,62x0,16x
Free Cash Flow -51,9---
ROE (Net Profit / Equities) -61,8%-32,1%--
Shareholders' equity1 91,7223--
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share ----
Cash Flow per Share2 -7,92-2,30-2,33-
Capex 1,00---
Capex / Sales 7,35%---
Announcement Date 03/25/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 732 122 182
Net sales (USD) 13 612 000
Number of employees 121
Sales / Employee (USD) 112 496
Free-Float 90,4%
Free-Float capitalization (USD) 662 046 392
Avg. Exchange 20 sessions (USD) 5 239 901
Average Daily Capital Traded 0,72%
EPS & Dividend